Resources

Selected
  • Pneumococcal disease
Type of publications
Regions
Diseases
Methodological quality (AMSTAR 2)

310 results found

2016 ∙ Diao, W. Q. Shen, N. Yu, P. X. Liu, B. B. He, B.

Efficacy of 23-valent pneumococcal polysaccharide vaccine in preventing community-acquired pneumonia among immunocompetent adults: A systematic review and meta-analysis of randomized trials

  • Adolescents
  • Adults
  • Older adults
  • Pneumococcal disease
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2016 ∙ Schiffner-Rohe, J. Witt, A. Hemmerling, J. Von Eiff, C. Leverkus, F. W.

Efficacy of PPV23 in preventing pneumococcal pneumonia in adults at increased risk - A systematic review and meta-analysis

  • Adults
  • Older adults
  • Pneumococcal disease
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2016 ∙ DeAntonio, R. Yarzabal, J. P. Cruz, J. P. Schmidt, J. E. Kleijnen, J.

Epidemiology of community-acquired pneumonia and implications for vaccination of children living in developing and newly industrialized countries: A systematic literature review

  • Newborn
  • Children
  • Low and Middle Income Countries
  • Haemophilus influenzae type B
  • Pneumococcal disease
  • Coverage
Methodological quality (AMSTAR 2):
Not applicable
2016 ∙ Puges, M. Biscay, P. Barnetche, T. Truchetet, M. E. Richez, C. Seneschal, J. Gensous, N. Lazaro, E. Duffau, P.

Immunogenicity and impact on disease activity of influenza and pneumococcal vaccines in systemic lupus erythematosus: a systematic literature review and meta-analysis

  • Adults
  • Older adults
  • Influenza
  • Pneumococcal disease
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2016 ∙ de Oliveira, L. H. Camacho, L. A. Coutinho, E. S. Martinez-Silveira, M. S. Carvalho, A. F. Ruiz-Matus, C. Toscano, C. M.

Impact and Effectiveness of 10 and 13-Valent Pneumococcal Conjugate Vaccines on Hospitalization and Mortality in Children Aged Less than 5 Years in Latin American Countries: A Systematic Review

  • Americas
  • Newborn
  • Children
  • Pneumococcal disease
  • Efficacy/effectiveness
  • Administration
Methodological quality (AMSTAR 2):
High
2016 ∙ Dyda, A. Karki, S. Hayen, A. MacIntyre, C. R. Menzies, R. Banks, E. Kaldor, J. M. Liu, B.

Influenza and pneumococcal vaccination in Australian adults: A systematic review of coverage and factors associated with uptake

  • Western Pacific
  • Australia
  • Adults
  • Influenza
  • Pneumococcal disease
  • Coverage
Methodological quality (AMSTAR 2):
Not applicable
2016 ∙ La Torre, G. Mannocci, A. Colamesta, V. D'Egidio, V. Sestili, C. Spadea, A.

Influenza and pneumococcal vaccination in hematological malignancies: A systematic review of efficacy, effectiveness, and safety

  • All age groups
  • Influenza
  • Pneumococcal disease
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2016 ∙ Ciapponi, A. Lee, A. Bardach, A. Glujovsky, D. Rey-Ares, L. Luisa Cafferata, M. Valanzasca, P. Garcia Marti, S.

Interchangeability between Pneumococcal Conjugate Vaccines: A Systematic Review and Meta-Analysis

  • Newborn
  • Children
  • Pneumococcal disease
  • Administration
  • Efficacy/effectiveness
  • Safety
  • Economic aspects
Methodological quality (AMSTAR 2):
Critically low
2016 ∙ Barbieri, Marco Capri, Stefano

Is vaccination good value for money? A review of cost-utility analyses of vaccination strategies in eight european countries

  • Europe
  • All age groups
  • Human papillomavirus (HPV)
  • Pneumococcal disease
  • Varicella
  • Influenza
  • Rotavirus
  • Economic aspects
Methodological quality (AMSTAR 2):
Not applicable
2016 ∙ Harris, J. A. Moniz, M. H. Iott, B. Power, R. Griggs, J. J.

Obesity and the receipt of influenza and pneumococcal vaccination: A systematic review and meta-analysis

  • Adults
  • Older adults
  • Influenza
  • Pneumococcal disease
  • Coverage
Methodological quality (AMSTAR 2):
Not applicable
Loading...